AlzChem Group Gestion
Gestion contrôle des critères 2/4
We currently do not have sufficient information about the CEO.
Informations clés
Andreas Niedermaier
Directeur général
€1.5m
Rémunération totale
| Pourcentage du salaire du PDG | 20.9% |
| Durée du mandat du directeur général | 13.1yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 11.5yrs |
Mises à jour récentes de la gestion
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01
AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05Recent updates
AlzChem Group AG's (ETR:ACT) Shares Leap 26% Yet They're Still Not Telling The Full Story
Oct 27When Should You Buy AlzChem Group AG (ETR:ACT)?
Oct 18AlzChem Group (ETR:ACT) Has A Pretty Healthy Balance Sheet
Sep 07A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)
Jun 04AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising
May 08Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?
Apr 07AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?
Mar 23AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 10Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 24Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)
Feb 11
Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €46m |
| Mar 31 2024 | n/a | n/a | €39m |
| Dec 31 2023 | €2m | €315k | €35m |
| Sep 30 2023 | n/a | n/a | €30m |
| Jun 30 2023 | n/a | n/a | €28m |
| Mar 31 2023 | n/a | n/a | €30m |
| Dec 31 2022 | €818k | €315k | €30m |
| Sep 30 2022 | n/a | n/a | €29m |
| Jun 30 2022 | n/a | n/a | €28m |
| Mar 31 2022 | n/a | n/a | €27m |
| Dec 31 2021 | €890k | €300k | €28m |
| Sep 30 2021 | n/a | n/a | €27m |
| Jun 30 2021 | n/a | n/a | €26m |
| Mar 31 2021 | n/a | n/a | €23m |
| Dec 31 2020 | €786k | €300k | €20m |
| Sep 30 2020 | n/a | n/a | €16m |
| Jun 30 2020 | n/a | n/a | €17m |
| Mar 31 2020 | n/a | n/a | €17m |
| Dec 31 2019 | €915k | €260k | €18m |
| Sep 30 2019 | n/a | n/a | €19m |
| Jun 30 2019 | n/a | n/a | €18m |
| Mar 31 2019 | n/a | n/a | €20m |
| Dec 31 2018 | n/a | n/a | €23m |
| Sep 30 2018 | n/a | n/a | €22m |
| Jun 30 2018 | €453k | €110k | €32m |
| Mar 31 2018 | n/a | n/a | €21m |
| Dec 31 2017 | €1m | €220k | €20m |
Rémunération vs marché: Andreas's total compensation ($USD1.65M) is above average for companies of similar size in the German market ($USD1.08M).
Rémunération et revenus: Andreas's compensation has increased by more than 20% in the past year.
PDG
Andreas Niedermaier (55 yo)
13.1yrs
Titularisation
€1,509,000
Compensation
Mr. Andreas Niedermaier has been Chairman of Executive Board & Chief Executive Officer at AlzChem Group AG since July 01, 2019 and has been its Member of Management Board since October 20, 2011. He served...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Chairman of Executive Board | 13.1yrs | €1.51m | pas de données | |
| Member of Executive Board & COO | 8.8yrs | €1.24m | pas de données | |
| Chief Sales Officer & Member of Executive Board | 5.3yrs | €1.24m | pas de données | |
| CFO & Member of Management Board | less than a year | pas de données | pas de données |
7.0yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Gestion expérimentée: ACT's management team is seasoned and experienced (7 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman of the Supervisory Board | 15.1yrs | €42.00k | pas de données | |
| Independent Member of the Supervisory Board | 8yrs | €24.00k | pas de données | |
| Deputy Chairman of the Supervisory Board | 8yrs | €32.00k | pas de données | |
| Member of the Supervisory Board | 15.1yrs | €22.00k | pas de données |
11.5yrs
Durée moyenne de l'emploi
53.5yo
Âge moyen
Conseil d'administration expérimenté: ACT's board of directors are seasoned and experienced ( 11.5 years average tenure).